BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 11127750)

  • 21. Rescreening in cervical cytology for quality control. When bad data is worse than no data or what works, what doesn't, and why.
    Renshaw AA
    Clin Lab Med; 2003 Sep; 23(3):695-708. PubMed ID: 14560535
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Cervical-vaginal smears: an unpopular test!].
    Gompel C
    Presse Med; 1998 Jun; 27(20):971-3. PubMed ID: 9767844
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thin-layer technology: tempered enthusiasm.
    Kurtycz DF; Hoerl HD
    Diagn Cytopathol; 2000 Jul; 23(1):1-5. PubMed ID: 10907923
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adequacy of cellular material in split-sampling of cervical scrapings for routine cancer screening: an analysis of 702 smears.
    Othman N; Othman NH
    Malays J Pathol; 2012 Dec; 34(2):115-21. PubMed ID: 23424773
    [TBL] [Abstract][Full Text] [Related]  

  • 25. European guidelines for quality assurance in cervical cancer screening: recommendations for collecting samples for conventional and liquid-based cytology.
    Arbyn M; Herbert A; Schenck U; Nieminen P; Jordan J; Mcgoogan E; Patnick J; Bergeron C; Baldauf JJ; Klinkhamer P; Bulten J; Martin-Hirsch P
    Cytopathology; 2007 Jun; 18(3):133-9. PubMed ID: 17573762
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Recommendations for quality control of cervico-vaginal cytology].
    GISCi, Gruppo Italiano Screening del Cervicocarcinoma
    Epidemiol Prev; 2004; 28(1 Suppl):1-16. PubMed ID: 15202448
    [No Abstract]   [Full Text] [Related]  

  • 27. Performance of monolayered cervical smears in a gynecology outpatient setting in Kuwait.
    Luthra UK; Chishti M; Dey P; Jolly SV; Abdulla M; Das DK; Sugathan TN; Ajrawi MT; George J; George SS; Aziz AA; al-Juwaiser A; Karim FA; Mallik MK; Sheikh ZA; Khan S
    Acta Cytol; 2002; 46(2):303-10. PubMed ID: 11917577
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In-house quality assurance program in a state cytology laboratory.
    Gardner NM
    Acta Cytol; 1989; 33(4):487-8. PubMed ID: 2750439
    [TBL] [Abstract][Full Text] [Related]  

  • 29. European guidelines on cervical screening.
    Smith JH; Desai MS
    Cytopathology; 2007 Aug; 18(4):211-2. PubMed ID: 17635160
    [No Abstract]   [Full Text] [Related]  

  • 30. Overview of the cytology laboratory: specimen processing through diagnosis.
    Joste N
    Obstet Gynecol Clin North Am; 2008 Dec; 35(4):549-63; viii. PubMed ID: 19061816
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Daily peer review of abnormal cervical smears in the assessment of individual practice as an additional method of internal quality control.
    Confortini M; Di Stefano C; Biggeri A; Bulgaresi P; Di Claudio G; Grisotto L; Maddau C; Matucci M; Petreschi C; Troni GM; Turco P; Foxi P
    Cytopathology; 2016 Feb; 27(1):35-42. PubMed ID: 25123613
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improving the adequacy of Pap smears.
    Baker RM
    Am Fam Physician; 1989 Jun; 39(6):109-14. PubMed ID: 2729036
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pap smear refined.
    Oncology (Williston Park); 1997 Aug; 11(8):1125. PubMed ID: 9268975
    [No Abstract]   [Full Text] [Related]  

  • 34. Which are more correctly diagnosed: conventional Papanicolaou smears or Thinprep samples? A comparative study of 9 years of external quality-assurance testing.
    Cummings MC; Marquart L; Pelecanos AM; Perkins G; Papadimos D; O'Rourke P; Ross JA
    Cancer Cytopathol; 2015 Feb; 123(2):108-16. PubMed ID: 25487287
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ASCCP patient management guidelines: Pap test specimen adequacy and quality indicators.
    Davey DD; Austin RM; Birdsong G; Buck HW; Cox JT; Darragh TM; Elgert PA; Hanson V; Henry MR; Waldman J;
    Am J Clin Pathol; 2002 Nov; 118(5):714-8. PubMed ID: 12428791
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of the quality of Papanicolaou smears on the detection of cytologic abnormalities.
    Mintzer M; Curtis P; Resnick JC; Morrell D
    Cancer; 1999 Jun; 87(3):113-7. PubMed ID: 10385441
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Does speculum lubricant affect liquid-based Papanicolaou test adequacy?
    Lin SN; Taylor J; Alperstein S; Hoda R; Holcomb K
    Cancer Cytopathol; 2014 Mar; 122(3):221-6. PubMed ID: 24254917
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Update on the Papanicolaou smear: new issues for the 1990s.
    Ollayos CW
    Mil Med; 1997 Aug; 162(8):521-3. PubMed ID: 9271901
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Papanicolaou smear cell recovery techniques used by primary care physicians.
    Clement KD; Christenson PD
    J Am Board Fam Pract; 1990; 3(4):253-8. PubMed ID: 2248091
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Accuracy of reporting endocervical component adequacy--a continuous quality improvement project.
    Roberson J; Connolly K; St John K; Eltoum I; Chhieng DC
    Diagn Cytopathol; 2002 Sep; 27(3):181-4. PubMed ID: 12203868
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.